CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential.

Area of Science:

• Immunology
• Cellular Biology
• Oncology

Background:

• CD8 T cells are vital for immune surveillance, fighting infections and cancer.
• Upon antigen exposure, naive CD8 T cells develop effector functions to eliminate harmful cells.
• Traditionally, cytotoxic T cells were considered the primary effector CD8 T cell subset.

Purpose of the Study:

• To review recent advancements in understanding CD8 T cell subsets.
• To explore the roles of these distinct subsets in various disease pathologies.
• To highlight the therapeutic potential of targeting specific CD8 T cell subsets.

Main Methods:

• Literature review of recent studies on CD8 T cell subsets.
• Analysis of effector functions and therapeutic applications.
• Synthesis of current knowledge on CD8 T cell heterogeneity.

Main Results:

• Emerging evidence identifies distinct effector CD8 T cell subsets beyond traditional cytotoxic T cells.
• These subsets possess unique effector functions and therapeutic potential.
• Understanding this diversity is crucial for deciphering immune responses in disease.

Conclusions:

• Distinct CD8 T cell subsets have unique roles in immune responses and disease.
• Targeting specific CD8 T cell subsets offers promising strategies for precision medicine.
• Further research into CD8 T cell heterogeneity will advance immunotherapeutic development.